These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 9754934

  • 1. Cocaine sensitization prevents the hypolocomotor effects of high but not low doses of PD 128,907.
    Prinssen EP, Koek W, Kleven MS.
    Eur J Pharmacol; 1998 Aug 14; 355(1):19-22. PubMed ID: 9754934
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907).
    van Vliet LA, Rodenhuis N, Dijkstra D, Wikström H, Pugsley TA, Serpa KA, Meltzer LT, Heffner TG, Wise LD, Lajiness ME, Huff RM, Svensson K, Sundell S, Lundmark M.
    J Med Chem; 2000 Jul 27; 43(15):2871-82. PubMed ID: 10956195
    [Abstract] [Full Text] [Related]

  • 3. Protection against cocaine toxicity in mice by the dopamine D3/D2 agonist R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol [(+)-PD 128,907].
    Witkin JM, Dijkstra D, Levant B, Akunne HC, Zapata A, Peters S, Shannon HE, Gasior M.
    J Pharmacol Exp Ther; 2004 Mar 27; 308(3):957-64. PubMed ID: 14711932
    [Abstract] [Full Text] [Related]

  • 4. The dopamine D3/D2 agonist (+)-PD-128,907 [(R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol)] protects against acute and cocaine-kindled seizures in mice: further evidence for the involvement of D3 receptors.
    Witkin JM, Levant B, Zapata A, Kaminski R, Gasior M.
    J Pharmacol Exp Ther; 2008 Sep 27; 326(3):930-8. PubMed ID: 18566292
    [Abstract] [Full Text] [Related]

  • 5. Analysis of D2 and D3 receptor-selective ligands in rats trained to discriminate cocaine from saline.
    Garner KJ, Baker LE.
    Pharmacol Biochem Behav; 1999 Oct 27; 64(2):373-8. PubMed ID: 10515316
    [Abstract] [Full Text] [Related]

  • 6. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B, Katz JL, Alling K, Acri JB, Witkin JM.
    J Pharmacol Exp Ther; 1997 Oct 27; 283(1):7-15. PubMed ID: 9336302
    [Abstract] [Full Text] [Related]

  • 7. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.
    Pugsley TA, Davis MD, Akunne HC, MacKenzie RG, Shih YH, Damsma G, Wikstrom H, Whetzel SZ, Georgic LM, Cooke LW.
    J Pharmacol Exp Ther; 1995 Dec 27; 275(3):1355-66. PubMed ID: 8531103
    [Abstract] [Full Text] [Related]

  • 8. Dopamine D2 receptors play a role in the (-)-apomorphine-like discriminative stimulus effects of (+)-PD 128907.
    Kleven MS, Koek W.
    Eur J Pharmacol; 1997 Feb 19; 321(1):1-4. PubMed ID: 9083778
    [Abstract] [Full Text] [Related]

  • 9. Dopamine D3 agonists disrupt social behavior in rats.
    Kagaya T, Yonaga M, Furuya Y, Hashimoto T, Kuroki J, Nishizawa Y.
    Brain Res; 1996 May 20; 721(1-2):229-32. PubMed ID: 8793104
    [Abstract] [Full Text] [Related]

  • 10. Atypical antipsychotic-like effects of the dopamine D3 receptor agonist, (+)-PD 128,907.
    Witkin J, Gasior M, Acri J, Beekman M, Thurkauf A, Yuan J, DeBoer P, Wikström H, Dijkstra D.
    Eur J Pharmacol; 1998 Apr 24; 347(2-3):R1-3. PubMed ID: 9741997
    [Abstract] [Full Text] [Related]

  • 11. Ontogeny of the motor inhibitory role of dopamine D(3) receptor subtype in rats.
    Heijtz RD, Ogren SO, Fuxe K.
    Eur J Pharmacol; 2000 Mar 24; 392(1-2):35-9. PubMed ID: 10748270
    [Abstract] [Full Text] [Related]

  • 12. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
    Collins GT, Witkin JM, Newman AH, Svensson KA, Grundt P, Cao J, Woods JH.
    J Pharmacol Exp Ther; 2005 Jul 24; 314(1):310-9. PubMed ID: 15833897
    [Abstract] [Full Text] [Related]

  • 13. Altered behavioral response to dopamine D3 receptor agonists 7-OH-DPAT and PD 128907 following repetitive amphetamine administration.
    Richtand NM, Welge JA, Levant B, Logue AD, Hayes S, Pritchard LM, Geracioti TD, Coolen LM, Berger SP.
    Neuropsychopharmacology; 2003 Aug 24; 28(8):1422-32. PubMed ID: 12700693
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of dopamine D3 receptor antagonists on spontaneous and agonist-reduced motor activity in NMRI mice and Wistar rats: comparative study with nafadotride, U 99194A and SB 277011.
    Gyertyán I, Sághy K.
    Behav Pharmacol; 2004 Jul 24; 15(4):253-62. PubMed ID: 15252275
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 7-OH-DPAT and PD 128907 selectively activate the D3 dopamine receptor in a novel environment.
    Pritchard LM, Logue AD, Hayes S, Welge JA, Xu M, Zhang J, Berger SP, Richtand NM.
    Neuropsychopharmacology; 2003 Jan 24; 28(1):100-7. PubMed ID: 12496945
    [Abstract] [Full Text] [Related]

  • 19. Repeated intravenous cocaine administration: locomotor activity and dopamine D2/D3 receptors.
    Wallace DR, Mactutus CF, Booze RM.
    Synapse; 1996 Jul 24; 23(3):152-63. PubMed ID: 8807743
    [Abstract] [Full Text] [Related]

  • 20. Effects of adenosine A(2A) receptor stimulation in vivo on dopamine D3 receptor agonist binding in the rat brain.
    Hillefors M, Hedlund PB, von Euler G.
    Biochem Pharmacol; 1999 Dec 15; 58(12):1961-4. PubMed ID: 10591151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.